## PAYC: Paycom Software, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 1.1% below STRENGTH zone (3.0-6.0%); PEG 1.41 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.5% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($155.20)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 4
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Paycom (PAYC) Stock Is Up, What You Need To Know**
- Source: TradingView â€” Track All Markets | 20251217T180827 | Neutral | Relevance: 100%
- Shares of HR software provider Paycom (PAYC) jumped after BTIG initiated coverage with a "Buy" rating and a $195 price target. This positive analyst view led to an initial stock rise, although it later cooled, closing up 2.7%. The move is considered meaningful by the market, especially given the stock's relatively low volatility and a previous 13.3% drop due to disappointing Q3 earnings.

**2. Paycom (PAYC): Assessing Valuation After Mixed Q3 Results, CFO Share Sale and Revised Growth Outlook**
- Source: Simply Wall Street | 20251216T103424 | Neutral | Relevance: 100%
- Paycom (PAYC) is under renewed scrutiny after reporting mixed Q3 results, which saw earnings per share fall short while revenue exceeded forecasts. Despite the recent CFO share sale and a nearly 30% drop in share price over the past year, the company is considered "22.4% Undervalued" by Simply Wall St, with a narrative fair value near $209.94. This valuation is driven by expectations of automation and AI-fueled product innovation, though potential risks like pricing pressure from AI adoption could impact its competitive moat.

**3. BTIG Research Reiterates "Buy" Rating for Paycom Software (NYSE:PAYC)**
- Source: MarketBeat | 20251217T135042 | Neutral | Relevance: 100%
- BTIG Research has reaffirmed its "Buy" rating for Paycom Software (NYSE:PAYC), setting a price target of $195.00, which suggests a 19.6% upside. Despite this, the overall analyst consensus for Paycom is a "Hold" with a target price of $223.57, as several other analysts have recently lowered their price targets due to missed earnings estimates. The company reported quarterly revenue of $493.3 million, up 9.2% year-over-year, but earnings per share of $1.94 missed estimates by $0.02.

**4. Paychex expected to report higher revenue and earnings for Q2 FY26**
- Source: AlphaStreet | 20251217T000804 | Neutral | Relevance: 62%
- Paychex (NASDAQ: PAYX) is projected to report increased revenue and earnings for Q2 FY26, driven by its AI-driven transformation, expanded market presence, and resilient recurring revenue base. Analysts anticipate an 18% year-over-year rise in revenues to $1.55 billion and an adjusted profit of $1.23 per share. The company's stock has underperformed but shows signs of improved investor sentiment, with its valuation highlighting a potential entry point for long-term investors.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 4 ($0.53M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.6% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 10.3% (+3.2%)
- Blackrock Inc.: 7.1% (+0.8%)
- Polen Capital Manage: 4.7% (-9.0%)
- FMR, LLC: 4.3% (-4.1%)
- State Street Corpora: 3.8% (+2.8%)

### Key Risks

1. Long-term trend broken: trading 23.7% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.41 suggests fair value with growth premium. Quality metrics strong (ROE 29%, margin 23%). Institutional flow bearish (5 selling vs 5 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $9.2B |
| Beta | 0.84 |
| 52W Range | $156.50 - $267.76 |
| Short Interest | 6.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.41 |
| Forward P/E | 16.3 |
| Current P/E | 17.7 |
| YoY Growth | 8.3% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 2.6% to 1.1% (-1.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.9pp (needs >3.0% for momentum thesis). MRS_5 (-0.2%) diverging from MRS_10 - short-term weakness emerging. Below SMA200 (0.76x), long-term trend not supportive. MACD histogram positive (1.33), confirming momentum. RSI neutral at 44. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.08% (CS: 51) | Neutral |
| RSI_14 | 44.1 | Neutral |
| MACD Histogram | 1.33 | Bullish |
| vs SMA20 | 1.005x | Above |
| vs SMA50 | 0.929x | Below |
| vs SMA200 | 0.763x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $164.28
- **Stop Loss:** $155.20 (5.5% risk)
- **Target:** $173.36 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 104
- **Position Value:** $17,085.12
- **Portfolio %:** 17.09%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-02-11 (Est: $2.45)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.97 | $1.94 | -1.6% |
| 2025Q2 | $1.78 | $2.06 | +15.6% |
| 2025Q1 | $2.56 | $2.80 | +9.4% |
| 2024Q4 | $1.97 | $2.32 | +17.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*